Key facts
- Notable investors include Guangzhou Jinkong Fund, Beijing Zhongguancun Collaborative Innovation Investment Fund Management, Green Finance Holdings.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Shiyun Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shiyun Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shiyun Biotechnology
Operator of a biotechnology enterprise intended to develop and deliver integrated cancer diagnostics and therapeutics. The company offers nucleic-acid delivery technology and molecular diagnostic methods, enabling oncologists and cancer patients access to a comprehensive system for accurate tumour detection and guided treatment.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Shiyun Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shiyun Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shiyun Biotechnology in its N-PORT filings yet. We sweep new filings monthly.